Institutional investors purchased a net $3.7 million shares of INCY during the quarter ended March 2015 and now own 95.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SV LIFE SCIENCES MANAGERS LLP Bought 106.4 Thousand shares of Incyte Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 62.0 Thousand shares of Incyte Corp